Free Trial

Illinois Municipal Retirement Fund Sells 14,765 Shares of The Clorox Company (NYSE:CLX)

Clorox logo with Consumer Staples background

Illinois Municipal Retirement Fund lessened its holdings in shares of The Clorox Company (NYSE:CLX - Free Report) by 18.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 64,531 shares of the company's stock after selling 14,765 shares during the quarter. Illinois Municipal Retirement Fund owned approximately 0.05% of Clorox worth $10,480,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently bought and sold shares of CLX. Brooklyn Investment Group increased its position in Clorox by 163.8% during the fourth quarter. Brooklyn Investment Group now owns 153 shares of the company's stock worth $25,000 after buying an additional 95 shares during the last quarter. Prospera Private Wealth LLC acquired a new position in Clorox during the third quarter worth approximately $27,000. Continuum Advisory LLC increased its position in Clorox by 300.0% during the third quarter. Continuum Advisory LLC now owns 184 shares of the company's stock worth $30,000 after buying an additional 138 shares during the last quarter. Asset Planning Inc acquired a new position in Clorox during the fourth quarter worth approximately $32,000. Finally, BankPlus Trust Department acquired a new position in shares of Clorox in the fourth quarter valued at approximately $40,000. Institutional investors and hedge funds own 78.53% of the company's stock.

Clorox Price Performance

NYSE CLX traded up $2.14 on Friday, hitting $156.52. 1,498,518 shares of the company's stock were exchanged, compared to its average volume of 1,378,293. The stock has a 50-day moving average of $156.88 and a 200-day moving average of $160.15. The company has a current ratio of 0.94, a quick ratio of 0.60 and a debt-to-equity ratio of 20.52. The Clorox Company has a 52 week low of $127.60 and a 52 week high of $171.37. The stock has a market cap of $19.28 billion, a price-to-earnings ratio of 42.76, a P/E/G ratio of 2.62 and a beta of 0.42.

Clorox (NYSE:CLX - Get Free Report) last released its earnings results on Monday, February 3rd. The company reported $1.55 earnings per share for the quarter, topping the consensus estimate of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same quarter in the previous year, the firm earned $2.16 earnings per share. Analysts expect that The Clorox Company will post 7.15 earnings per share for the current year.

Clorox Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, May 9th. Shareholders of record on Wednesday, April 23rd will be paid a dividend of $1.22 per share. This represents a $4.88 annualized dividend and a yield of 3.12%. The ex-dividend date of this dividend is Wednesday, April 23rd. Clorox's payout ratio is presently 133.33%.

Analyst Ratings Changes

Several equities analysts have recently commented on the company. DA Davidson decreased their target price on Clorox from $171.00 to $169.00 and set a "neutral" rating on the stock in a research report on Wednesday, February 5th. TD Cowen raised Clorox from a "sell" rating to a "hold" rating and upped their target price for the company from $155.00 to $170.00 in a research report on Wednesday, November 6th. JPMorgan Chase & Co. upped their target price on Clorox from $171.00 to $173.00 and gave the company a "neutral" rating in a research report on Tuesday, February 4th. StockNews.com downgraded Clorox from a "buy" rating to a "hold" rating in a research report on Sunday, January 5th. Finally, Evercore ISI upped their target price on Clorox from $145.00 to $155.00 in a research report on Tuesday, February 4th. Four investment analysts have rated the stock with a sell rating, eleven have given a hold rating and one has assigned a buy rating to the stock. According to data from MarketBeat, Clorox presently has an average rating of "Hold" and an average price target of $158.21.

View Our Latest Report on Clorox

Clorox Company Profile

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Featured Stories

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Should You Invest $1,000 in Clorox Right Now?

Before you consider Clorox, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clorox wasn't on the list.

While Clorox currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

7 Inflation-Proof Stocks to Protect Your Portfolio

7 Inflation-Proof Stocks to Protect Your Portfolio

Inflation is sticking around—is your portfolio ready? In this video, we break down 7 stocks that could help shield your investments from inflation’s impact.

Related Videos

7 Large-Cap Stocks Headed for Strong, Steady Gains in 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines